Legal & Regulatory
bcbs-gender-affirming-policy-doc-require-highlighted.pdf
Documents & Forms Results
Displaying 1011 - 1020 of 3636 results
Legal & Regulatory
bcbs-gender-affirming-policy-hrt-language-highlighted.pdf
Provider
QP88-22 Provider Press: Q2 2022
Program effective Date: Oct 26, 2022
Provider
QP89-22 Provider Press: Q3 2022
Program effective Date: Oct 26, 2022
Provider
QP87-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Strensiq® (asfotase alfa)
Program effective Date: Oct 26, 2022
Provider
QP86-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Vtama® (tapinarof)
Program effective Date: Oct 26, 2022
Provider
QP84-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Camzyos™ (mavacamten)
Program effective Date: Oct 26, 2022
Provider
QP85-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Radicava® (edaravone)
Program effective Date: Oct 26, 2022
Provider
QP83-22 MHCP Pharmacy Benefit Exclusion for Somatuline® Depot and Sandostatin® LAR Depot
Program effective Date: Oct 26, 2022
Provider
QP82-22 MHCP Pharmacy Benefit Update New drug-related PA with QL Criteria Vijoice® (alpelisib)
Program effective Date: Oct 12, 2022